Abstract
Background/Objectives: Laparoscopic sleeve gastrectomy (SG) is the most performed bariatric procedure, providing effective weight loss and comorbidity improvement. However, its association with new-onset or worsening gastroesophageal reflux disease (GERD) remains a limitation. To address this, fundoplication sleeve gastrectomy (FSG) has been proposed by combining SG with an anti-reflux procedure. This systematic review and meta-analysis evaluates the efficacy and safety of FSG in patients with severe obesity. Methods: PubMed, Scopus, and Web of Science were systematically searched up to December 2023. Eligible studies included adults with BMI ≥ 40 kg/m2 or ≥35 kg/m2 with comorbidities undergoing FSG or SG with ≥12 months of follow-up. Random-effects meta-analysis compared FSG and SG in terms of weight loss, postoperative GERD, and complications. Results: Twelve studies (n = 543) were included; five contributed to the meta-analysis. Pooled analysis showed no significant difference in percentage of excess weight loss (%EWL) between FSG and SG (Hedges’ g = −0.11; 95% CI: −0.99–0.76; I2 = 86%), and similar %TWL outcomes (Hedges’ g = −0.28; 95% CI: −0.70–0.13). FSG demonstrated a significantly lower postoperative GERD prevalence (RR = 0.08; 95% CI: 0.01–0.47) and greater GERD resolution (RR = 1.86; 95% CI: 0.80–4.20), but higher complication (RR = 2.95; 95% CI: 1.02–8.50) and reoperation rates (RR = 4.39; 95% CI: 1.47–13.12). Conclusions: FSG achieves weight loss comparable to SG and may reduce postoperative GERD prevalence, but carries an increased complication and reoperation risk. Further randomized trials with standardized GERD definitions and longer follow-up are required.